Vertebral Compression Fracture Devices Market by Product Type (Balloon Kyphoplasty Devices and Vertebroplasty Devices), Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery): Global Opportunity Analysis and Industry Forecast, 2020–2030
- ALL4676824
- 150 Pages
- September 2021
- Diagnostic and Biotech
The global vertebral compression fracture devices market was valued at $866.70 million in 2020, and is projected to reach $1,909.40 million by 2030, registering a CAGR of 8.10% from 2021 to 2030, owing to the factors like increase in the prevalence of increase in geriatric population, shift towards the minimally invasive spine procedures, rise in incidence of osteoporosis & arthritis, and growth in patient awareness about advancements in spinal surgeries, such as artificial disc replacement. However, some of the factors like risks associated with post-surgical complications including hemorrhage and vertebral posterior element fracture, stringent regulatory approval procedures and unfavorable reimbursement scenarios are expected to hamper the market growth.
The vertebral compression fracture devices market is segmented on the basis on product type, surgery, and region. By type of product, the market is bifurcated into balloon kyphoplasty devices and vertebroplasty devices. By surgery, the market is divided into open spine surgery and minimally invasive spine surgery. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The COVID-19 pandemic is an unprecedented global public health challenge and is anticipated to have a negative impact on the vertebral compression fracture devices market. The COVID-19 pandemic and subsequent economic slowdown has materially impacted the demand for vertebral compression fracture devices, which are used in procedures that are considered elective for the treatment. Moreover, the slowdown in supply chain of the vertebral compression fracture devices had increased the demand and supply gap. This increase has led to slowdown of the production plants of the devices. Government imposed the restrictions on the use of staff which resulted in the slowdown and shutdown of various manufacturing companies. This shutdown resulted in the decrease of growth factor of the vertebral compression fracture devices market.
On the basis of product type, the vertebral compression fracture devices market is categorized into balloon kyphoplasty devices and vertebroplasty devices. The balloon kyphoplasty devices segment is expected to gain highest revenue during the forecast period. This is attributed to the surge in incidences of osteoporosis & arthritis. In addition, the boost in number of geriatric population would propel the market growth in the next few years. However, vertebroplasty segment is expected to generate significant revenue shares in the vertebral compression fracture market.
On the basis of surgery, the vertebral compression fracture market is classified into open spine surgery and minimally invasive spine surgery. The minimally invasive spine surgery segment is anticipated to gain the highest revenue during the forecast period, owing to the increase in incidences of spinal disorders which needs early diagnosis. In addition, the growing awareness among the population about the procedures would help the segment generate higher revenue shares in the coming years.
North America is constituted to have highest market share of the vertebral compression fracture market in 2020, followed by the other sectors. The larger share of the North America region can be attributed to the factors such as ease of availability of the devices and services across developing countries, rise in health awareness among the people. Overall, it is projected that the need for the vertebral compression fracture in developing and developed regions of North America would rise sharply in the coming years.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysis market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By product type
o Balloon kyphoplasty devices
o Vertebroplasty devices
By surgery
o Open spine surgery
o Minimally invasive spine surgery
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
• Alphatec Holdings, Inc.
• Benvenue Medical
• Globus Medical, Inc.
• Johnson & Johnson (Depuy Synthes)
• Medtronic plc
• Orthovita, Inc.
• Osseon LLC
• Stryker Corporation
• VEXIM SA
• Zimmer Biomet Holdings, Inc.
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in the geriatric population
3.5.1.2.Increase in the prevalence of spine disorders
3.5.1.3.Shift towards minimally invasive spine procedures
3.5.2.Restraint
3.5.2.1.Unfavorable reimbursement scenarios
3.5.3.Opportunities
3.5.3.1.Emerging markets to drive the demand for VCF devices
3.5.4.Impact analysis
3.6.COVID-19 Impact Analysis on Vertebral compression fracture devices Market
CHAPTER 4:VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Balloon kyphoplasty
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Vertebroplasty
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY
5.1.Overview
5.1.1.Market size and forecast
5.2.Open spine surgery
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Minimally Invasive Spine Surgery
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.3.1.U.S.
6.2.3.1.1.U.S. Vertebral compression fracture devices market, by product
6.2.3.1.2.U.S. Vertebral compression fracture devices market, By Surgery
6.2.3.2.Canada
6.2.3.2.1.Canada Vertebral compression fracture devices market, by product
6.2.3.2.2.Canada Vertebral compression fracture devices market, By Surgery
6.2.3.3.Mexico
6.2.3.3.1.Mexico Vertebral compression fracture devices market, by product
6.2.3.3.2.Mexico Vertebral compression fracture devices market, By Surgery
6.2.4.North America market size and forecast, by product
6.2.5.North America market size and forecast, By Surgery
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany Vertebral compression fracture devices market, by product
6.3.2.1.2.Germany Vertebral compression fracture devices market, By Surgery
6.3.2.2.France
6.3.2.2.1.France Vertebral compression fracture devices market, by product
6.3.2.2.2.France Vertebral compression fracture devices market, By Surgery
6.3.2.3.UK
6.3.2.3.1.UK Vertebral compression fracture devices market, by product
6.3.2.3.2.UK Vertebral compression fracture devices market, By Surgery
6.3.2.4.Italy
6.3.2.4.1.Italy Vertebral compression fracture devices market, by product
6.3.2.4.2.Italy Vertebral compression fracture devices market, By Surgery
6.3.2.5.Spain
6.3.2.5.1.Spain Vertebral compression fracture devices market, by product
6.3.2.5.2.Spain Vertebral compression fracture devices market, By Surgery
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe Vertebral compression fracture devices market, by product
6.3.2.6.2.Rest of Europe Vertebral compression fracture devices market, By Surgery
6.3.3.Europe market size and forecast, by product
6.3.4.Europe market size and forecast, By Surgery
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan
6.4.2.1.1.Japan Vertebral compression fracture devices market, by product
6.4.2.1.2.Japan Vertebral compression fracture devices market, By Surgery
6.4.2.2.China
6.4.2.2.1.China Vertebral compression fracture devices market, by product
6.4.2.2.2.China Vertebral compression fracture devices market, By Surgery
6.4.2.3.Australia
6.4.2.3.1.Australia Vertebral compression fracture devices market, by product
6.4.2.3.2.Australia Vertebral compression fracture devices market, By Surgery
6.4.2.4.India
6.4.2.4.1.India Vertebral compression fracture devices market, by product
6.4.2.4.2.India Vertebral compression fracture devices market, By Surgery
6.4.2.5.South Korea
6.4.2.5.1.South Korea Vertebral compression fracture devices market, by product
6.4.2.5.2.South Korea Vertebral compression fracture devices market, By Surgery
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific Vertebral compression fracture devices market, by product
6.4.2.6.2.Rest of Asia-Pacific Vertebral compression fracture devices market, By Surgery
6.4.3.Asia-Pacific market size and forecast, by product
6.4.4.Asia-Pacific market size and forecast, By Surgery
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil Vertebral compression fracture devices market, by product
6.5.2.1.2.Brazil Vertebral compression fracture devices market, By Surgery
6.5.2.2.Saudi Arabia
6.5.2.2.1.Saudi Arabia Vertebral compression fracture devices market, by product
6.5.2.2.2.Saudi Arabia Vertebral compression fracture devices market, By Surgery
6.5.2.3.South Africa
6.5.2.3.1.South Africa Vertebral compression fracture devices market, by product
6.5.2.3.2.South Africa Vertebral compression fracture devices market, By Surgery
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA Vertebral compression fracture devices market, by product
6.5.2.4.2.Rest of LAMEA Vertebral compression fracture devices market, By Surgery
6.5.3.LAMEA market size and forecast, by product
6.5.4.LAMEA market size and forecast, By Surgery
CHAPTER 7:COMPANY PROFILES
7.1.ALPHATEC HOLDINGS INC.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.BENVENUE MEDICAL INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments
7.3.GLOBUS MEDICAL, INC.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.JOHNSON & JOHNSON (DEPUY SYNTHES)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.MEDTRONIC PLC
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MERIT MEDICAL SYSTEMS, INC.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.SPINE WAVE INC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.8.SPIRIT SPINE HOLDINGS CORPORATION INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.STRYKER CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.ZIMMER BIOMET HOLDINGS, INC.,
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
TABLE 01.GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.BALLOON KYPHOPLASTY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 03.VERTEBROPLASTY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 04.GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 05.OPEN SPINE SURGERY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 06.MINIMALLY INVASIVE SPINE SURGERY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 07.VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 10.U.S. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 11.U.S. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 12.CANADA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 13.CANADA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 14.MEXICO VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 15.MEXICO VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 18.EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 19.GERMANY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 20.GERMANY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 21.FRANCE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 22.FRANCE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 23.UK VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 24.UK VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 25.ITALY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 26.ITALY VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 27.SPAIN VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 28.SPAIN VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 29.REST OF EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 30.REST OF EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 31.EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 32.EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 33.ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 34.JAPAN VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 35.JAPAN VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 36.CHINA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 37.CHINA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 38.AUSTRALIA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 39.AUSTRALIA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 40.INDIA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 41.INDIA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 42.SOUTH KOREA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 43.SOUTH KOREA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 44.REST OF ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 45.REST OF ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 46.ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 47.ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 48.LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 49.BRAZIL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 50.BRAZIL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 51.SAUDI ARABIA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 52.SAUDI ARABIA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 53.SOUTH AFRICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 54.SOUTH AFRICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 55.REST OF LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 56.REST OF LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 57.LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 58.LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY, 2020–2030 ($MILLION)
TABLE 59.ALPHATEC HOLDINGS: COMPANY SNAPSHOT
TABLE 60.ALPHATEC HOLDINGS: OPERATING SEGMENTS
TABLE 61.ALPHATEC HOLDINGS: PRODUCT PORTFOLIO
TABLE 62.ALPHATEC HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63.BENVENUE MEDICAL: COMPANY SNAPSHOT
TABLE 64.BENVENUE MEDICAL: OPERATING SEGMENTS
TABLE 65.BENVENUE MEDICAL PRODUCT PORTFOLIO
TABLE 66.BENVENUE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 67.GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 68.GLOBUS MEDICAL: OERATING SEGMENT
TABLE 69.GLOBUS MEDICAL.: PRODUCT PORTFOLIO
TABLE 70.GLOBUS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 71.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 72.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 73.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 74.MEDTRONIC: COMPANY SNAPSHOT
TABLE 75.MEDTRONIC: OPERATING SEGMENTS
TABLE 76.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 77.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78.MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 79.MERIT MEDICAL SYSTEMS: OPERATING SEGMENTS
TABLE 80.MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 81.SPINE WAVE: COMPANY SNAPSHOT
TABLE 82.SPINE WAVE: OERATING SEGMENT
TABLE 83.SPINE WAVE: PRODUCT PORTFOLIO
TABLE 84.SPIRIT SPINE: COMPANY SNAPSHOT
TABLE 85.SPIRIT SPINE: OPERATING SEGMENTS
TABLE 86.SPIRIT SPINE: PRODUCT PORTFOLIO
TABLE 87.STRYKER: COMPANY SNAPSHOT
TABLE 88.STRYKER: OPERATING SEGMENTS
TABLE 89.STRYKER: PRODUCT PORTFOLIO
TABLE 90.STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 93.ZIMMER BIOMET: PRODUCT PORTFOLIO
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
